| Trial ID: | L1544 |
| Source ID: | NCT00247507
|
| Associated Drug: |
Acetylcysteine
|
| Title: |
The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Anemia|Atherosclerosis|End-Stage Renal Disease|Oxidative Stress|Pro-Inflammation
|
| Interventions: |
DRUG: acetylcysteine
|
| Outcome Measures: |
Primary: the changes of plasma ox-LDL levels|the changes of anemia status|the responsiveness to EPO therapy and severity of atherosclerosis |
|
| Sponsor/Collaborators: |
Sponsor: Far Eastern Memorial Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-09
|
| Completion Date: |
2005-12
|
| Results First Posted: |
|
| Last Update Posted: |
2006-10-18
|
| Locations: |
Far Eastern Memorial Hospital, Pan-Chiao, Taipei, 220, Taiwan
|
| URL: |
https://clinicaltrials.gov/show/NCT00247507
|
